Bio-Path Holdings, Inc.
BPTH
$0.14
-$0.005-3.45%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 808.00K | 1.32M | 1.17M | 1.41M | 757.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.63M | 2.63M | 3.04M | 3.70M | 3.03M |
| Operating Income | -2.63M | -2.63M | -3.04M | -3.70M | -3.03M |
| Income Before Tax | -2.75M | -2.12M | -1.87M | -3.16M | -3.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.75M | -2.12M | -1.87M | -3.16M | -3.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.75M | -2.12M | -1.87M | -3.16M | -3.37M |
| EBIT | -2.63M | -2.63M | -3.04M | -3.70M | -3.03M |
| EBITDA | -2.61M | -2.63M | -3.03M | -3.67M | -3.02M |
| EPS Basic | -0.64 | -0.70 | -1.16 | -4.88 | -5.50 |
| Normalized Basic EPS | -0.40 | -0.44 | -0.72 | -3.05 | -3.44 |
| EPS Diluted | -0.64 | -0.70 | -1.16 | -4.88 | -5.50 |
| Normalized Diluted EPS | -0.40 | -0.44 | -0.72 | -3.05 | -3.44 |
| Average Basic Shares Outstanding | 4.32M | 3.02M | 1.61M | 647.00K | 613.00K |
| Average Diluted Shares Outstanding | 4.32M | 3.02M | 1.61M | 647.00K | 613.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |